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ABSTRACT
INTRODUCTION A comprehensive smoking ban was recently enacted for acute-care 
hospital campuses in Spain. The aim of this study was to assess the prevalence 
and patterns of smoking among inpatients before and during hospitalization.
METHODS Multi-center cross-sectional study was conducted in 13 hospitals in 
the province of Barcelona, Spain from May 2014 to May 2015. Participants 
were adults who provided informed consent. The sample size was calculated 
to be representative of each hospital (prevalence 29.4%, precision ± 5%, error 
5%). We approached 1228 subjects, 888 accepted to participate and 170 
were replaced (were not available or declined to participate). Final sample 
comprised 1047 subjects. We used a computer-assisted personal interview 
system to collect data, including sociodemographic variables and use of 
tobacco before and during hospitalization. Smoking status was validated 
with exhaled carbon monoxide. We calculated overall tobacco prevalence 
and investigated associations with participant and center characteristics. We 
performed multiple polytomous and multilevel logistic regression analyses 
to estimate odds ratios (ORs) and 95% confidence intervals (CIs), with 
adjustments for potential confounders.
RESULTS In all, 20.5% (95% CI: 18.1–23.0) of hospitalized patients were smokers. 
Smoking was most common among men (aOR=7.47; 95% CI: 4.88–11.43), 
young age groups (18–64 years), and individuals with primary or less than 
primary education (aOR=2.76; 95% CI: 1.44–5.28). Of the smokers, 97.2% 
were daily consumers of whom 44.9% had medium nicotine dependence. 
Of all smokers, three-quarters expressed a wish to quit, and one-quarter 
admitted to consuming tobacco during hospitalization. 
CONCLUSIONS Our findings indicate the need to offer smoking cessation 
interventions among hospitalized patients in all units and service areas, 
to avoid infringements and increase patient safety, hospital efficiency, and 
improve clinical outcomes. Hospitalization represents a promising window 
for initiating smoking interventions addressed to all patients admitted to 
smoke-free hospitals, specially after applying a smoke-free campus ban.
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INTRODUCTION
Tobacco consumption is responsible for one-sixth 
of the 6 million annual deaths caused by non-
communicable diseases worldwide, including 
cardiovascular diseases, chronic respiratory diseases 
and cancer1. In 2005, the Framework Convention on 
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Tobacco Control (FCTC) promoted several policies 
to tackle the tobacco epidemic. Of these policies, 
Article 8 proposed smoking bans and Article 14 
directed countries to implement effective programs 
to assist individuals in quitting tobacco use2. In 
addition, the FCTC asserted that health organizations 
and healthcare professionals should act as examples 
in controlling tobacco consumption, championing 
compliance with the law, and providing smoking 
cessation aids3.
The scientific literature has shown that tobacco 
control policies adopted in healthcare organizations 
have mainly achieved changes in organizations 
and workers. These changes include reductions 
in smoking prevalence, increases in the number 
of attempts to quit smoking among health 
professionals4-6, and increases in the number 
of tobacco cessation interventions available7,8. 
However, only a small number of these studies have 
evaluated the impact of these measures on patients 
that consume tobacco. Smoking among hospitalized 
patients continues to be a widely neglected problem. 
Hospitalized patients exhibit a high smoking 
prevalence and frequent infringements of smoke-
free policies9-11. In Spain, the tobacco epidemic is 
at Stage IV, according to the cigarette epidemic 
model. This model shows a marked downturn in 
smoking prevalence among men and women and 
a decline of deaths attributable to smoking among 
men, but an increase among women12. According 
to the latest Spanish National Health Survey, 
tobacco consumption among adults (≥15 years 
old) has dropped from 38.7% in 200113 to 25.4% 
in 201414. Despite this important decline, tobacco-
related diseases continue to cause 15.2% of the 
total mortality in Spain15. Approximately 5 million 
individuals receive medical or surgical treatment in 
acute-care hospitals annually in Spain16, of whom 
about 1 million are smokers. 
In 2011, Spain established one of the most 
comprehensive tobacco control regulation policies 
in Europe for healthcare services17. The Spanish 
legislation pioneered an innovative legal framework 
that banned smoking in indoor and outdoor areas 
of acute-care hospitals. Responsibility was given 
to hospital management and health regional 
administrators to provide effective smoking 
cessation interventions, including counseling and 
pharmacological therapy, to address the needs of 
hospitalized patients that consumed tobacco18. 
Once the new Spanish legislation was established, 
the opportunity arose for evaluating the impact 
of tobacco control laws among inpatients and 
for assessing determinants of smoking during 
hospitalization. The ultimate goal of these studies 
is to improve our understanding of the needs 
of patients that attempt to quit smoking. This 
information would facilitate the design of tobacco 
cessation services and interventions for initiating 
attempts to quit smoking in a supportive, smoke-
free environment. Therefore, this study aimed to 
assess the prevalence, determinants, and patterns of 
smoking before and during hospital admission, in 13 
hospitals in the province of Barcelona, Spain.
METHODS
Design
In this multi-center cross-sectional study, we 
conducted a survey of a random sample of 
hospitalized patients admitted to 13 acute-care 
hospitals in Barcelona province (Northeast Spain), 
which comprises an area of 7.733 km2 of 5.5 million 
inhabitants. Hospitals were selected by convenience 
from the 38 acute-care hospitals that belonged to the 
Catalan Network for Smoke-free Hospitals (XCHsF, 
www.xchsf.com) in Barcelona province. 
Participants
Volunteers participated in the study. Participants 
were hospitalized adults (≥18 years), conscious and 
oriented in space, time, and person, with a stay ≥24 
hours. All participants provided informed consent. 
Patients that were hospitalized from the emergency 
room and intensive care units were excluded.
Sample sizes were calculated to be representative 
of each hospital and, after weighting, representative 
of all of Catalonia. Estimation of the sample size for 
each hospital took into account the total number of 
acute-care beds and the available regional smoking 
prevalence in Catalonia (29.4%)19. The required sample 
size was 1034 subjects, assuming a precision of ± 5% 
and an error of 5%. The calculation was performed 
with Statcalc in EpiInfo, version 6.0.4 (Centers for 
Disease Control and Prevention, Atlanta, US).
In each hospital, individuals were randomly 
selected from the daily updated admission list. The 
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randomization system for selecting participants was 
based on four steps: 1) the number of cases in each 
hospital was divided by the number of beds, 2) a 
random number was selected between one and the 
value attained in step one, 3) the first selection was 
the case number that matched the number chosen 
in step two, 4) the next case was selected by adding 
the selected number in step two to the number 
obtained in step one. For example, for a hospital 
with 350 beds, the sample size needed to account 
for 70 patients. Next, we divided the bed number 
(350) of the hospital by the sample number (70) 
of participants selected, i.e. 350/70=5. We chose a 
random number between 1 and 5 (e.g. 3). We began 
selecting the participants with that number (e.g. 3) 
and the 5th case patients were invited to participate. 
Thus, our invitation list became: 3, 8, 13, 18, and so 
on. 
When a selected patient corresponded to an empty 
bed or a patient that was unavailable (for instance, 
in a test) or when the patient declined to participate, 
we invited the next patient on the list that fulfilled 
the inclusion and exclusion criteria. In each survey, 
this type of substitution accounted for less than 16% 
of the corresponding sample. Thus, we approached 
1228 subjects in total, 888 accepted to participate 
and 170 were replaced (80% were not available 
and 20% declined to participate at the time of the 
interview). From the overall 1058 questionnaires 
obtained, 9 were excluded from the analysis because 
>20% of their content was blank (Figure 1).
Data collection 
We used an ad hoc questionnaire developed by 
an expert working group from the XCHsF (www.
xchsf.com). This questionnaire was composed of 86 
questions exploring several dimensions, however for 
the purpose of this study the main outcome variable 
was tobacco consumption that was defined according 
to WHO criteria20. Respondents were classified 
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into three categories: 1) current smoker, defined 
as a person that smoked regularly, either daily (at 
least one cigarette per day – CPD) or occasionally 
(less than one CPD) at the time of the survey; 2) 
non-smoker, defined as a person that had never 
smoked or had smoked less than 100 cigarettes in 
his/her lifetime; and 3) former smoker, defined as a 
person that smoked in the past, but had quit at least 
6 months prior to the study. Subjects were asked 
about their tobacco consumption before and during 
their hospital admission. 
To assess smoking patterns, current and former 
smokers were asked at what age they had started 
smoking and the number of cigarettes smoked per 
day. Among current smokers, we assessed what type 
of tobacco product they used (cigarettes, roll your 
own – RYO, electronic cigarettes, cigars, or pipe); the 
number of cigarettes smoked per day (CPD; classified 
as <10, 10–19, and ≥20); and the time to the first 
cigarette after waking (≤5, 6–30, 31–60, >60 min). 
Nicotine dependence was assessed with the Heavy 
Smoking Index (HSI), a six-point scale calculated 
from the number of cigarettes smoked per day and 
the time to the first cigarette after waking. The HSI 
scores were categorized into three levels of nicotine 
dependence: low (0–2), medium (3–4), and high (5–
6)21. Withdrawal symptoms were assessed according 
to DSM-IV categories. Smokers also reported 
whether they had abstained from smoking during 
hospitalization (yes/no). We measured exhaled 
carbon monoxide (CO) to validate abstinence with 
a CO-oximeter. The cutoff value for active tobacco 
consumption was set at 6 particles per million 
(ppm)22. We assessed the readiness to quit with the 
Prochaska and DiClemente change model stages that 
include: pre-contemplative, contemplative, active, 
maintenance, and relapse23.
The main descriptive variables relating to patients 
were: 1) sociodemographics, such as sex and age 
(classified as <45 years, 45–64 years, >64 years, 
based on the median distribution); 2) educational 
level (less than primary, primary, high school, and 
university); 3) occupation (employed, unemployed, 
retired, other – students and homecare roles); 4) 
partner’s smoking status (no partner, non-smoking 
partner, smoking partner); 5) self-perceived health 
status (excellent, very good, good, adequate, or 
poor); 6) independence index, according to the 
Barthel index (100 independent, <100 dependent); 
and 7) comorbidities.
In addition, we explored the following variables 
relating to hospitals: 1) the level of technology of 
the center (general or high-technology hospital); 2) 
type of ward (the original ward was noted, but later 
categorized as surgical, medical-surgical, or medical); 
3) number of beds (≤300, >300); 4) smoking 
prevalence among health professionals (≤30%, >30%, 
based on records in the Catalan Network for Smoke-
free Hospitals files (XCHsF); 5) smoking cessation 
program at the hospital (yes, no); 6) accreditation 
level, according to XCHsF standards (gold, silver, 
bronze, and member). 
The questionnaire had been tested previously with 
a pilot sample of participants in one hospital. During 
the pilot testing a couple of questions were slightly 
changed mainly because interviewers mentioned 
that patients did not understand them. For example, 
instead of employing the term ‘e-health’ we asked 
current smokers and former smokers whether they 
have used webs, apps, and other Internet resources 
for quitting. We collected data with a computer-
assisted personal interview (CAPI) system. Trained 
interviewers conducted the interviews face-to-face, 
from May 2014 to May 2015.
Ethical considerations
The study protocol was approved by the Ethics 
Committee of the Hospital Universitari de Bellvitge 
(PR234/11). All participants provided written 
consent to participate. 
Data analysis 
Descriptive analyses were performed on participant 
and center characteristics. Tobacco consumption 
prevalence was computed overall, according to sex, 
and for each center. Direct standardization was used 
to control for age. The reference population was all 
the participants in the study, and the following age 
groups were used for standardization: 18–29, 30–39, 
40–49, 50–59, 60–69, and ≥70 years. 
The main outcome variable was smoking status 
(current smoker, former smoker, and non smoker). 
A bivariate analysis was carried out with logistic 
regression to estimate the association between the 
main outcome variables and the sociodemographic 
and center characteristics. To identify the main 
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determinants that characterized a smoker and/
or former smoker, we fitted polytomous logistic 
regression models. Results are presented as crude 
odds ratio (cOR) or adjusted OR (aOR), as a measure 
of association. We used a multilevel logistic regression 
model, due to the variability in the prevalence of 
tobacco use among centers. Statistical significance 
was set at p<0.05. Analyses were conducted with SPSS 
version 21 and STATA version 13. The weights from 
the sample design were applied to all calculations. 
RESULTS
Sociodemographic data
The final sample comprised 1047 subjects. The 
number of participants per hospital ranged 
from 41 to 205. Table 1 shows the participant 
Table 1. Smoking status according to  variables that represent patient characteristics (Hospitals of Barcelona 
Province, 2014–2015 )
Overall Current smokers Former smokers Non-smokers
n %1 95% CI n %2 95% CI n %2 95% CI n %2 95% CI
Overall 1047 100 – 215 20.5 (18.1 – 23.0) 346 33.1 (30.2 – 35.9) 486 46.4 (43.4 – 49.4)
Sex
Female 520 49.7 (46.6 – 52.7) 70 13.5 (10.5 – 16.4) 95 18.3 (14.9 – 21.6) 355 68.2 (64.3 – 72.3)
Male 527 50.3 (47.3 – 53.4) 145 27.5 (23.7 – 31.3) 251 47.6 (43.4 – 51.9) 131 24.9 (21.2 – 28.5)
Age groups (years)
<45 255 24.4 (21.8 – 27.0) 81 31.8 (26.1 – 37.5) 49 19.2 (14.4 – 24.1) 125 49.0 (42.9 – 55.2)
45–64 314 30.0 (27.2 – 32.8) 96 30.6 (25.5 – 35.7) 122 38.8 (33.5 – 44.2) 96 30.6 (25.5 – 35.7)
>64 478 45.6 (42.6 – 48.7) 38 7.9 (5.5 – 10.4) 175 36.7 (32.3 – 40.9) 265 55.4 (51.0 – 59.9)
Education
Less than primary 360 34.5 (31.6 – 37.4) 46 12.8 (9.3 – 16.2) 113 31.4 (26.6 – 36.2) 201 55.8 (50.7 – 61.0)
Primary 330 31.6 (28.8 – 34.4) 95 28.8 (23.9 – 33.7) 111 33.6 (28.5 – 38.7) 124 37.6 (32.4 – 42.8)
High School 213 20.4 (18.0 – 22.8) 55 25.8 (19.9 – 31.7) 68 31.9 (25.7 – 38.2) 90 42.3 (35.6 – 48.9)
University 141 13.5 (11.4 – 15.6) 19 13.5 (7.8 – 19.1) 54 38.3 (30.3 – 46.3) 68 48.2 (40.0 – 56.5)
Occupation
Employed 321 30.7 (27.9 – 33.5) 101 31.5 (26.4 – 36.5) 92 28.7 (23.7 – 33.6) 128 39.8 (34.5 – 45.2)
Unemployed 77 7.4 (5.8 – 8.9) 30 38.9 (28.1 – 49.9) 17 22.1 (12.8 – 31.3) 30 39.0 (28.1 – 49.9)
Retired 532 50.7 (47.8 – 53.8) 75 14.1 (11.1 – 17.1) 227 42.7 (38.5 – 46.9) 230 43.2 (39.0 – 47.4)
Others 117 11.2 (9.3 – 13.1) 9 7.7 (2.9 – 12.5) 10 8.5 (3.5 – 13.6) 98 83.8 (77.1 – 90.4)
Partner's smoking status
No partner 312 29.9 (27.1 – 32.6) 74 23.7 (19.0 – 28.4) 76 24.4 (19.6 – 29.1) 162 51.9 (46.4 – 57.5)
Non-smoker partner 563 53.8 (50.9 – 56.9) 68 12.1 (9.4 – 14.8) 224 39.8 (35.7 – 43.8) 271 48.1 (44.0 – 52.3)
Smoker partner 170 16.3 (14.0 – 18.5) 72 42.3 (34.9 – 49.8) 46 27.1 (20.4 – 33.7) 52 30.6 (23.7 – 37.5)
Perceived health status
Excellent/Very good 164 15.7 (13.5 – 17.9) 39 23.8 (17.3 – 30.3) 39 23.8 (17.3 – 30.3) 86 52.4 (44.8 – 60.1)
Good 453 43.2 (40.3 – 46.3) 100 22.1 (18.3 – 25.9) 148 32.7 (28.4 – 37.0) 205 45.2 (40.7 – 49.8)
Adequate/Poor 430 41.1 (38.1 – 44.0) 76 17.7 (14.1 – 21.3) 159 37.0 (32.4 – 41.5) 195 45.3 (40.6 – 50.1)
Barthel Index
Dependent (<100) 230 22.0 (19.5 – 24.5) 28 12.2 (7.9 – 16.4) 83 36.1 (29.9 – 42.3) 119 51.7 (45.3 – 58.2)
Independent (100) 817 78.0 (75.5 – 80.5) 187 22.9 (20.0 – 25.8) 263 32.2 (29.0 – 35.4) 367 44.9 (41.5 – 48.3)
Comorbidities*
Arterial hypertension 431 41.2 (38.2 – 44.1) 56 13.0 (9.8 – 16.2) 166 38.5 (33.9 – 43.1) 209 48.5 (43.8 – 53.2)
Diabetes 270 25.8 (23.1 – 28.4) 33 12.2 (8.3 – 16.1) 106 39.3 (33.4 – 45.1) 131 48.5 (42.6 – 54.5)
Pneumonia 216 20.6 (18.2 – 23.1) 30 13.9 (9.3 – 18.5) 103 47.7 (41.0 – 54.3) 83 38.4 (31.9 – 44.9)
Kidney diseases 201 19.2 (16.8 – 21.6) 24 11.9 (7.5 – 16.4) 93 46.3 (39.4 – 53.2) 84 41.8 (35.0 – 48.6)
Chronic liver diseases 129 12.3 (10.3 – 14.3) 30 23.3 (16.0 – 30.5) 49 38.0 (29.6 – 46.4) 50 38.7 (30.4 – 47.2)
Cancer 256 24.5 (21.8 – 27.1) 45 17.6 (12.9 – 22.2) 105 41.0 (35.0 – 47.0) 106 41.4 (35.4 – 47.4)
Heart diseases 258 24.6  (22 – 27.3) 33 12.8 (8.7 – 16.9) 99 38.4 (32.4 – 44.3) 126 48.8 (42.7 – 54.9)
Cerebrovascular diseases 108 10.3 (8.5 – 12.2) 13 12.0 (5.9 – 18.2) 35 32.4 (23.6 – 41.2) 60 55.6 (46.2 – 64.9)
Respiratory diseases 208 19.9 (17.4 – 22.3) 44 21.2 (15.6 – 26.7) 84 40.3 (33.7 – 47.1) 80 38.5 (31.8 – 45.1)
Exhaled carbon monoxide
CO ≤6 ppm 588 56.2 (53.2 – 59.2) 78 13.3 (10.5 – 16.0) 197 33.5 (29.7 – 37.3) 313 53.2 (49.2 – 57.3)
CO >6 ppm 260 24.8 (22.2 – 27.4) 103 39.6 (33.7 – 45.6) 78 30.0 (24.4 – 35.6) 79 30.4 (24.8 – 36.0)
*Multiple responses allowed. CI: confidence interval. 1 Column %. 2 Row %.
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sociodemographic characteristics and the main 
variables. In brief, half of participants were men, 
predominantly >64 years old (45.6%). The majority 
had less than primary or primary education 
(66.1%), were retired (50.6%), and with a non-
smoking partner (53.8%). Before hospitalization, 
most declared that they were in good (43.2%) or 
adequate to poor health (41.1%), and most (78.0%) 
completed daily activities independently (without 
assistance). 
Overall, 20.5% (95% CI: 18.1–23.0) of respondents 
were current smokers; this proportion varied by 
hospital, with a range of 14.7 to 30.3% (Figure 2). 
By sex, 27.5% of men were smokers (95% CI: 23.7–
31.3) and 13.5% were women (95% CI: 10.5–16.4). 
The highest smoking prevalence was observed in the 
youngest group, <45 years, for both men and women 
(men 47.2%, 95% CI: 36.8–57.6; women 23.5%, 95% 
CI: 17.0–29.9), compared to the middle age group, 
45–64 years, (men 38.1%, 95% CI: 31.2–45.0; women 
19.2%, 95% CI: 12.3–26.1), and the older age group, 
>64 years, (men 12.4%, 95% CI: 8.3–16.6; women 
3.1%, 95% CI: 0.8–5.3). Among the current smokers, 
38.9% were unemployed, 31.5% were employed, and 
42.3% had a partner that also smoked. 
Former smokers comprised 33.1% of all patients, 
and significantly different proportions of former 
smokers were observed between the sexes and 
among different age groups (Table 1). 
Smoking status  accord ing to  hosp i ta l 
characteristics
Table 2 summarizes the smoking status of patients 
in hospitals with different characteristics. The lowest Smoking prevalence (%)




















Figure 2. Age-standardized prevalence (%) of smoking, 
in participant hospitals of Barcelona Province, 
2014–2015 (The area of each dot represents the relative 
weighting of the hospital, in terms of the proportion 
of participants among the total, bars represent 95% CI, 
the diamond and the dotted line represent the overall 
weighted prevalence and 95% CI) 
Table 2. Smoking status  according to variables that represent hospital  characteristics (Hospitals of Barcelona 
Province, 2014–2015 )
Overall Current smokers Former smokers Non-smokers
n %1 95% CI n %2 95% CI n %2 95% CI n %2 95% CI
Level of center
General hospital 245 23.4 (20.8 – 26.0) 54 22.0 (16.9 – 27.2) 80 32.7 (26.8 – 38.5) 111 45.3 (39.1 – 51.5)
High-technology hospital 802 76.6 (74.0 – 79.2) 161 20.1 (17.3 – 22.8) 266 33.2 (29.9 – 36.4) 375 46.7 (43.3 – 50.2)
Type of ward
Surgical 361 34.5 (31.6 – 37.4) 75 20.8 (16.6 – 25.0) 118 32.7 (27.8 – 37.5) 168 46.5 (41.4 – 51.7)
Medical-Surgical 127 12.1 (10.2 – 14.1) 18 14.2 (8.1 – 20.2) 31 24.4 (16.9 – 31.9) 78 61.4 (53.0 – 69.9)
Medical 559 53.4 (50.4 – 56.4) 122 21.9 (18.4 – 25.2) 197 35.2 (31.3 – 39.2) 240 42.9 (38.8 – 47.0)
Continued
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smoking prevalence was observed among medical-
surgical wards. In the bivariate analysis, smoking 
prevalence was not significantly related to any of the 
explanatory variables we assessed that represented 
hospital characteristics. 
Smoking patterns among daily smokers before 
and during hospitalization 
Among all smokers, 97.2% were daily smokers 
(209/215). The majority of male smokers were 45–
64 years (49.6%, 95 CI%: 41.3–58.0); the majority 
of female smokers were ≤45 years (55.7%, 95 CI%: 
44.1–67.4). Both men and women smoked mainly 
manufactured cigarettes, but nearly one-quarter 
smoked RYO cigarettes. Other tobacco products 
(cigars, pipes, and e-cigarettes) were consumed 
based on anecdotal reports. The majority of smokers 
consumed exclusively manufactured cigarettes 
(75.6%), but 12.7% consumed only RYOs, and 11.7% 
combined these two tobacco products (Table 3). 
Before hospitalization, 44.1% of daily smokers 
consumed 10–19 CPD, and 72.7% consumed their 
first cigarette within the first 30 min of waking. 
Thus, 44.9% of smokers had an intermediate level 
of nicotine dependence according to the HSI. High 
levels of nicotine dependence were more frequently 
observed among male smokers than among female 
smokers, but the difference was not statistically 
significant (Table 3). 
A total 75.7% of daily smokers expressed their 
wish to quit smoking, if it could be done easily 
during hospitalization. Among all smokers, 38.1% 
had high interest in quitting now, and 21.3% had 
no interest in quitting. Men were more interested 
in quitting than women (Table 3). Among daily 
smokers, 24.2% admitted to consuming tobacco 
during hospitalization, and the proportion was similar 
between men and women. When analysing their 
length of stay and smoking during hospitalization, 
we observed that 31.6% of smokers with 1-day stay 
smoked during hospitalization versus 19.8% of those 
who were interviewed in their 2nd to 5th day of stay, 
and 26.5% of those with >5 days of stay (p=0.417). 
The average number of cigarettes consumed per 
day was 3 (range=1 to 20). Smokers who consumed 
tobacco did it 15.5% of the times inside the hospital 
(in their room, wc, stairs, terraces), 63.5% in outdoor 
areas belonging to the hospital (entrances, gardens, 
parkings, etc), and 21.0% outside the perimeter 
of the hospital. Smokers who consumed tobacco 
during hospitalization did not differ from those who 
remained abstinent from smoking, based on sex, 
age, nicotine dependence, and whether the hospital 
provided smoking cessation services. The percentage 
of smokers with exhaled carbon monoxide levels >6 
ppm was higher among male smokers than among 
female smokers (63.0% vs 48.2%, p=0.069) It 
is known, that smokers who remain abstinent for 
Overall Current smokers Former smokers Non-smokers
n %1 95% CI n %2 95% CI n %2 95% CI n %2 95% CI
Number of beds
≤300 541 51.7 (48.6 – 54.7) 111 20.5 (17.1 – 23.9) 176 32.5 (28.6 – 36.5) 254 47.0 (42.7 – 51.2)
>300 506 48.3 (45.3 – 51.4) 104 20.6 (17.0 – 24.1) 170 33.6 (29.5 – 37.7) 232 45.8 (41.5 – 50.2)
HP smoking prevalence 
<30%  801 76.5 (73.9 – 79.1) 160 20.0 (17.2 – 22.7) 265 33.1 (29.8 – 36.3) 376 46.9 (43.5 – 50.4)
≥30%  246 23.5 (20.9 – 26.1) 55 22.4 (17.2 – 27.6) 81 32.9 (27.1 – 38.8) 110 44.7 (38.5 – 50.9)
Smoking cessation program
Yes 813 77.7 (75.1 – 80.2) 165 20.3 (17.5 – 23.1) 273 33.6 (30.3 – 36.8) 375 46.1 (42.7 – 49.6)
No 234 22.3 (19.8 – 24.9) 50 21.4 (16.1 – 26.6) 73 31.2 (25.3 – 37.1) 111 47.4 (41.0 – 53.8)
Accreditation level
Gold 337 32.2 (29.4 – 35.0) 69 20.5 (16.2 – 24.8) 126 37.4 (32.2 – 42.6) 142 42.1 (36.9 – 47.4)
Silver 317 30.3 (27.5 – 33.1) 63 19.9 (15.5 – 24.3) 91 28.7 (23.7 – 33.7) 163 51.4 (45.9 – 56.9)
Bronze 147 14.0 (11.9 – 16.1) 28 19.0 (12.7 – 25.4) 48 32.7 (25.1 – 40.2) 71 48.3 (40.2 – 56.4)
Member 246 23.5 (20.9 – 26.1) 55 22.4 (17.2 – 27.6) 81 32.9 (27.1 – 38.8) 110 44.7 (38.5 – 50.9)
HP: health professionals. 1 Percentage per column. 2 Percentage per row.
ContinuedTable 2. 
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Table 3. Patterns of daily tobacco use, before and during hospitalization (Hospitals of Barcelona Province, 
2014–2015 )
Sex
Daily smokers (N=209 ) Men (N=139 ) Women (N=70 )
n % 95% CI n % 95% CI n % 95% CI
Age groups (years)
<45 79 37.8 (31.2 – 44.4) 40 28.8 (21.3 – 36.3) 39 55.7 (44.1 – 67.4)
45–64 93 44.5 (37.8 – 51.2) 69 49.6 (41.3 – 58.0) 24 34.3 (23.2 – 45.4)
>64 37 17.7 (12.5 – 22.9) 30 21.6 (14.7 – 28.4) 7 10.0 (3.0 – 17.0)
Before hospitalization       
Type of tobacco product consumed*
Manufactured cigarettes 179 85.6 (80.9 – 90.4) 116 83.5 (77.3 – 89.6) 63 90.0 (83.0 – 97.0)
RYO cigarettes 50 23.9 (18.1 – 29.7) 34 24.5 (17.3 – 31.6) 16 22.9 (13.0 – 32.7)
Electronic cigarettes 2 1.0    (0 – 2.3) 2 1.4    (0 – 3.4) 0 0.0    (0 – 0)
Cigars 14 6.7 (3.3 – 10.1) 14 10.1 (5.1 – 15.1) 0 0.0    (0 – 0)
Pipe 4 1.9 (0.1 – 3.8) 4 2.9 (0.1 – 5.7) 0 0.0    (0 – 0)
Combination of tobacco products
Only manufactured cigarettes 155 75.6 (69.7 – 81.5) 101 74.8 (67.5 – 82.1) 54 77.1 (67.3 – 87.0)
Only RYO cigarettes 26 12.7 (8.1 – 17.2) 19 14.1 (8.2 – 19.9) 7 10.0 (3.0 – 17.0)
Both 24 11.7 (7.3 – 16.1) 15 11.1 (5.8 – 16.4) 9 12.9 (5.0 – 20.7)
Number of cigarettes per day (manufactured + RYO)
<10 54 26.5 (20.4 – 32.5) 31 23.2 (16.0 – 30.3) 23 32.9 (21.9 – 43.9)
10–19 90 44.1 (37.3 – 50.9) 57 42.5 (34.2 – 50.9) 33 47.1 (35.4 – 58.8)
≥20 60 29.4 (23.2 – 35.7) 46 34.3 (26.3 – 42.4) 14 20.0 (10.6 – 29.4)
Time (min) to first cigarette after waking
≤30 152 72.7 (66.7 – 78.8) 98 70.5 (62.9 – 78.1) 54 77.1 (67.3 – 87.0)
>30 57 27.3 (21.2 – 33.3) 41 29.5 (21.9 – 37.1) 16 22.9 (13.0 – 32.7)
Heavy Smoking Index
High 39 18.7 (13.4 – 23.9) 28 20.2 (13.5 – 26.8) 11 15.7 (7.2 – 24.2)
Medium 94 44.9 (38.2 – 51.7) 59 42.4 (34.2 – 50.7) 35 50.0 (38.3 – 61.7)
Low 76 36.4 (29.8 – 42.9) 52 37.4 (29.4 – 45.5) 24 34.3 (23.2 – 45.4)
During hospitalization       
Would you like to quit smoking if you could do it easily?
Yes 153 75.7 (69.8 – 81.7) 106 77.4 (70.4 – 84.4) 47 72.3 (61.4 – 83.2)
No 49 24.3 (18.3 – 30.2) 31 22.6 (15.6 – 29.6) 18 27.7 (16.8 – 38.6)
How much interest do you have in quitting now?
None 43 21.3 (15.6 – 26.9) 25 18.7 (12.1 – 25.3) 18 26.5 (16.0 – 37.0)
Some 36 17.8 (12.5 – 23.1) 24 17.9 (11.4 – 24.4) 12 17.6 (8.6 – 26.7)
Sufficient 46 22.8 (17.0 – 28.6) 31 23.1 (16.0 – 30.3) 15 22.1 (12.2 – 31.9)
High 77 38.1 (31.4 – 44.8) 54 40.3 (32.0 – 48.6) 23 33.8 (22.6 – 45.1)
Cessation contemplation status
Precontemplative 77 38.5 (31.8 – 45.2) 47 34.8 (26.8 – 42.9) 30 46.2 (34.0 – 58.3)
Contemplative 55 27.5 (21.3 – 33.7) 37 27.4 (19.9 – 34.9) 18 27.7 (16.8 – 38.6)
Ready 35 17.5 (12.2 – 22.8) 26 19.3 (12.6 – 25.9) 9 13.8 (5.4 – 22.2)
Active 33 16.5 (11.4 – 21.6) 25 18.5 (12.0 – 25.1) 8 12.3 (4.3 – 20.3)
Tobacco use during hospitalization
No 157 75.8 (69.2 – 82.5) 105 76.6 (68.5 – 84.7) 52 74.3 (62.4 – 86.2)
Yes 50 24.2 (17.5 – 30.8) 32 23.4 (15.3 – 31.5) 18 25.7 (13.8 – 37.6)
Exhaled carbon monoxide (CO) ppm level
CO ≤6 73 41.7 (34.4 – 49.0) 44 37.0 (28.3 – 45.6) 29 51.8 (38.7 – 64.9)
CO >6 102 58.3 (51.0 – 65.6) 75 63.0 (54.4 – 71.7) 27 48.2 (35.1 – 61.3)
* Multiple responses allowed. RYO: roll your own cigarettes.
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more than 6 days might have lower CO levels22. Our 
results showed that 73.9% of smokers (with more 
than 5 days stay) who admitted to having smoked 
during hospitalization had a positive CO (> 6ppm) in 
contrast to 34.9% of those who remained abstinent 
(p=0.001).
Smoking patterns and sociodemographic 
characteristics of former smokers
Male former smokers were mostly >64 years, and 
female former smokers were significantly younger 
(45–64 years; p≤0.001, Table 4). Former smokers 
were more likely to have smoked daily, rather than 
occasionally, but a higher percentage of women 
than men had smoked occasionally. Among former 
daily smokers, we observed differences between the 
sexes. For example, the majority of men previously 
consumed ≥20 CPD (70.9%, 95% CI: 64.7–77.1) and 
a minority of women previously consumed ≥20 CPD 
(37.5%, 95% CI: 25.6–49.4; p<0.05). About 74.1% 
Table 4. Smoking pattern and sociodemographic characteristics among former smokers (n=346 ) (Hospitals of 
Barcelona Province, 2014–2015 )
Sex
Former smoker Men Women
n % 95% CI n % 95% CI n % 95% CI
Age groups (years)
<45 49 14.2 (10.5 – 17.8) 17 6.8 (3.7 – 9.9) 32 33.7 (24.2 – 43.2)
45–64 122 35.3 (30.2 – 40.3) 81 32.3 (26.5 – 38.1) 41 43.1 (33.2 – 53.1)
>64 175 50.5 (45.3 – 55.8) 153 60.9 (54.9 – 67.0) 22 23.2 (14.7 – 31.6)
Daily consumption
No (occasionals) 47 13.6 (9.7 – 17.5) 20 8.0 (4.5 – 11.5) 27 28.4 (17.7 – 39.1)
Yes 299 86.4 (82.5 – 90.3) 231 92.0 (88.5 – 95.5) 68 71.6 (60.9 – 82.3)
Number of cigarettes per day (manufactured + RYO) *
<10 40 14.8 (10.6 – 19.1) 19 9.2 (5.3 – 13.2) 21 32.8 (21.3 – 44.3)
10–19 60 22.2 (17.3 – 27.2) 41 19.9 (14.5 – 25.4) 19 29.7 (18.5 – 40.9)
≥20 170 63.0 (57.2 – 68.7) 146 70.9 (64.7 – 77.1) 24 37.5 (25.6 – 49.4)
Number of quit attempts
1–2 253 74.1 (69.5 – 78.8) 178 72.0 (66.5 – 77.7) 75 79.8 (71.7 – 87.9)
3–5 66 19.4 (15.2 – 23.5) 52 21.1 (16.0 – 26.1) 14 14.9 (7.7 – 22.1)
≥6 22 6.5 (3.8 – 9.1) 17 6.9 (3.7 – 10.0) 5 5.3 (0.8 – 9.9)
Reasons for quitting **
Doctor/nurse recommendation 110 31.8 (26.9 – 36.7) 93 26.9 (22.2 – 31.5) 17 4.9 (2.6 – 7.2)
Tobacco use annoyances 134 38.7 (33.6 – 43.9) 118 34.1 (29.1 – 39.1) 16 4.6 (2.4 – 6.8)
Health concerns 175 50.6 (45.3 – 55.8) 141 40.8 (35.6 – 45.9) 34 9.8 (6.7 – 13.0)
Decrease of my physical performance 75 21.7 (17.3 – 26.0) 66 19.1 (14.9 – 23.2) 9 2.6 (0.9 – 4.3)
Familial pressure 71 20.5 (16.3 – 24.8) 47 13.6 (10.0 – 17.2) 24 6.9 (4.3 – 9.6)
Personal decision 215 62.1 (57.0 – 67.2) 154 44.5 (39.3 – 49.7) 61 17.6 (13.6 – 21.6)
Economic reasons 21 6.1 (3.6 – 8.6) 14 4.0 (2.0 – 6.1) 7 2.0 (0.5 – 3.5)
Health problems (tobacco-related diseases) 15 4.3 (2.2 – 6.5) 12 3.5 (1.5 – 5.4) 3 0.9    (0 – 1.8)
Other reasons 35 10.1 (6.9 – 13.3) 20 5.8 (3.3 – 8.2) 15 4.3 (2.2 – 6.5)
Resources used to quit smoking **
Professional healthcare 31 9.0 (6.0 – 12.0) 26 7.5 (4.7 – 10.3) 5 1.4 (0.2 – 2.7)
Use of e-health technologies (apps. webs) 0 0.0    (0 – 0) 0 0.0    (0 – 0) 0 0.0    (0 – 0)
Self-help book 7 2.0 (0.5 – 3.5) 5 1.4 (0.2 – 2.7) 2 0.6    (0 – 1.4)
Other 7 2.0 (0.5 – 3.5) 6 1.7 (0.4 – 3.1) 1 0.3    (0 – 0.9)
None 302 87.3 (83.8 – 90.8) 216 62.4 (57.3 – 67.5) 86 24.9 (20.3 – 29.4)
Pharmacological treatment used
Yes 46 13.5 (9.9 – 17.2) 36 14.6 (10.2 – 19.1) 10 10.6 (4.4 – 16.9)
No 294 86.5 (82.8 – 90.1) 210 85.4 (80.9 – 89.8) 84 89.4 (83.1 – 95.6)
* Only daily consumers responded. ** Multiple response
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of former smokers had attempted to quit 1 or 2 
times before finally quitting. The two most reported 
reasons for quitting were their own personal decision 
and health concerns. Among former smokers, 87.3% 
did not use any resources to assist them in quitting, 
and 13.5% used a pharmacological treatment to quit 
(Table 4). 
Predictors associated with smokers and former 
smokers
Table 5 displays the aOR (adjusted for sex and age) 
that a current smoker or a former smoker would 
exhibit characteristics represented by patient-related 
and hospital-related explanatory variables. Current 
smokers were more likely to be young men. Tobacco 
consumption was more likely (aOR=2.76) to be 
observed among patients with primary or less than 
primary education levels, compared to patients with 
a university degree. No other significant relationship 
emerged between smoking and any of the hospital-
related variables studied. 
The odds ratio of being a former smoker was 
higher among men (aOR=5.85) compared to 
women. Smokers were more likely to be 30–69 years 
old, rather than >70 years old. Former smokers were 
most frequently patients with a university degree 
and patients that had retired from working. Patients 
admitted to medical-surgical wards were more likely 
to be former smokers than those in surgical wards 
(aOR=2.39). 
Table 5. Univariate and multivariate models of a current smoker or former smoker (Hospitals of Barcelona 
Province, 2014–2015 )
Current smoker Former smoker
Descriptive variables cOR 95% CI aOR 95% CI cOR 95% CI aOR 95% CI
Patient-related characteristics
Sex
Male 7.22 (4.88 – 10.68) 7.47 (4.88 – 11.43) 7.11 (5.15 – 9.80) 5.85 (4.16 – 8.22)
Female 1.00 1.00 1.00 1.00
Age groups (years)
18–29 7.56 (3.63 – 15.77) 8.24 (3.25 – 20.91) 0.48 (0.21 – 1.06) 0.74 (0.30 – 1.84)
30–39 11.07 (5.69 – 21.54) 11.55 (4.84 – 27.55) 1.46 (0.85 – 2.52) 1.63 (0.78 – 3.38)
40–49 13.32 (7.05 – 25.17) 11.48 (5.10 – 25.82) 1.22 (0.70 – 2.11) 1.41 (0.70 – 2.85)
50–59 11.76 (6.23 – 22.20) 10.01 (4.60 – 21.81) 2.35 (1.44 – 3.81) 2.83 (1.52 – 5.29)
60–69 3.50 (1.87 – 6.54) 3.70 (1.93 – 7.09) 1.47 (0.98 – 2.22) 1.58 (1.03 – 2.43)
> 70 1.00 1.00 1.00 1.00
Education
Primary or less 2.97 (1.61 – 5.49) 2.76 (1.44 – 5.28) 0.73 (0.45 – 1.18) 0.75 (0.46 – 1.24)
High School 1.88 (0.98 – 3.61) 1.45 (0.73 – 2.89) 0.76 (0.44 – 1.30) 0.73 (0.42 – 1.25)
University 1.00 1.00 1.00 1.00
Occupation
Unemployed 1.21 (0.65 – 2.24) 1.16 (0.59 – 2.29) 0.74 (0.37 – 1.50) 0.93 (0.45 – 1.91)
Retired 1.24 (0.69 – 2.21) 0.96 (0.52 – 1.78) 1.33 (0.77 – 2.27) 1.51 (0.87 – 2.62)
Other 0.34 (0.15 – 0.78) 0.29 (0.12 – 0.67) 0.30 (0.14 – 0.65) 0.35 (0.16 – 0.77)
Employed 1.00 1.00 1.00 1.00
Partner's smoking status
No partner 2.18 (1.40 – 3.39) 2.07 (1.31 – 3.27) 0.84 (0.58 – 1.21) 0.89 (0.61 – 1.29)
Smoker partner 5.75 (3.48 – 9.52) 6.01 (3.57 – 10.11) 1.53 (0.94 – 2.48) 1.50 (0.91 – 2.47)
Non-smoker partner 1.00 1.00 1.00 1.00
Perceived health status
Excellent/Very good 1.76 (1.00 – 3.07) 1.67 (1.00 – 2.79)
Good 1.30 (0.78 – 2.18) 1.30 (0.79 – 2.12)
Adequate/Poor 1.00 1.00
Barthel Index
Independent (100) 0.93 (0.54 – 1.57) 0.86 (0.59 – 1.26)
Dependent (<100) 1.00 1.00
Continued
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HP: health professional, cOR: odds ratio adjusted for age and sex, aOR: odds ratio fully adjusted for all the variables.
Table 5. Continued
Current smoker Former smoker
Descriptive variables cOR 95% CI aOR 95% CI cOR 95% CI aOR 95% CI
Hospital-related characteristics 
Level of center
General hospital 1.00 1.00
High-technology hospital 0.76 (0.50 – 1.16) 1.05 (0.73 – 1.51)
Type of ward
Surgical 1.00 1.00
Medical-Surgical 0.58 (0.29 – 1.18) 2.39 (1.26 – 4.54)
Medical 1.09 (0.74 – 1.63) 1.19 (0.85 – 1.67)
Number of beds
≤300 1.00 1.00
>300 1.00 (0.70 – 1.44) 0.98 (0.72 – 1.34)
HP smoking prevalence 
<30%  1.00 1.00
≥30%  1.51 (0.98 – 2.32) 1.01 (0.70 – 1.46)
Smoking cessation program
Yes 1.00 1.00
No 1.11 (0.72 – 1.72) 0.82 (0.57 – 1.19)
Accreditation level
Gold 1.00 1.00
Silver 0.75 (0.47 – 1.19) 0.75 (0.50 – 1.11)
Bronze 0.74 (0.41 – 1.34) 0.74 (0.46 – 1.21)
Member 1.27 (0.78 – 2.09) 0.86 (0.57 – 1.30)
DISCUSSION 
This study showed that smoking prevalence was 
high among hospitalized patients. Our findings 
indicate that hospitalized smokers comprised mainly 
males that were <64 years old, had primary or less 
than primary education, and had a partner with a 
smoking habit. The majority of smokers exhibited 
an intermediate nicotine dependence, and were 
mainly in precontemplative or contemplative stages 
of quitting. A quarter of smokers consumed tobacco 
during their hospital stay. 
Compared to the Catalan Health Survey (ESCA) 
results from 201424, adult hospitalized patients 
(>18 years) showed a lower overall prevalence of 
smokers than the general population older than 
15 years (20.5% vs 25.9%). Nonetheless, this 
might be due to the mean age of our study sample 
(hospitalized patients), which corresponded to an 
aging population. In fact, when comparing age 
groups, the overall prevalence of current smokers 
in the middle age group (45–64 years; 30.6%) was 
similar to that of the Catalan population between 
45–54 years (30.5%), but higher than the Catalan 
population between 55–65 years (21.9%)24. When 
comparing sex and age groups, our study found that 
47.2% of men <45 years were current smokers; in 
the Catalan population, the smoking prevalence was 
lower among men between 35–44 years (35.2%) and 
higher among men between 25–34 years (50.0%). 
Again, no differences were found between our 
sample and the Catalan population for individuals 
>65 years (men 12.4% vs 10.9%; women 3.1% vs 
4.5%, respectively)24. These results suggest that the 
prevalence of smokers among hospitalized patients 
was not different from that of the general population. 
This finding indicates that there is an opportunity for 
health care services to intervene in young patients 
that are not chronically ill, when they are treated in 
acute-care hospitals. 
Only two previous studies have monitored 
smoking consumption in hospitalized populations 
in Catalonia. The earlier study found a higher 
overall smoking prevalence (27.8% in 2002 and 
30.7% in 2004)25, and a later study found a slightly 
lower smoking prevalence (18.8% in 2006)26, 
compared to the overall prevalence reported 
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here (20.5%). These differences might be due 
to the differences in timing or design; the earlier 
studies were conducted 10 years ago and only in 
one center. In addition, the earlier investigations 
could have carried some selection bias, because not 
all hospital wards were included in the sampling 
strategies. This study is the first to monitor tobacco 
consumption among hospitalized patients from 
all wards in acute-care hospitals in our region. In 
the United States, a recent study that included all 
patients admitted to a General Hospital over 3 years 
(2007 to 2010) concluded that 21.1% of patients 
were smokers, and 18.4% had smoked during their 
hospital stay11. However, although our prevalence 
of tobacco consumption was similar, we found 
lower compliance with the smoke-free law than that 
found by Regan and colleagues11. This fact raised 
two safety concerns in our region. First, smoking 
may have direct, negative consequences that could 
delay recovery; and second, smoking could cause 
a fire, putting others in danger in the complicated 
context of a hospital. Consequently, hospitals in 
Catalonia should improve their communications 
about the smoke-free campus policy and about the 
risks of smoking during hospitalization. In addition, 
hospitals should monitor the implementation of the 
smoke-free compliance on a yearly basis.
In Catalonia, there are around 972995 annual 
hospitalizations27. According to our study, 20.5% 
of acute-care patients smoked, and of these, the 
majority expressed some or a high interest in 
quitting. Extending these proportions to all 
hospitalizations suggests that about 157000 
hospitalized smokers might be motivated to quit 
annually. In addition, as mentioned above, our 
profile of smokers in general hospitals indicates 
mainly young men. Thus, our data supports 
the notion that hospitalization could serve as a 
promising window of opportunity for approaching 
smokers and encouraging cessation28.  This 
opportunity has the advantages, in the context of 
a comprehensive smoke-free hospital, that smokers 
are obliged to abstain at least temporarily from 
tobacco use and that they are in regular contact 
with health professionals. A previous study found 
that between 60–70% of inpatients had attempted 
to quit smoking while they were hospitalized29. In 
the present study, about three-quarters of smokers 
expressed a wish to quit smoking, and about one-
third was ready to undertake an attempt. Therefore, 
hospitalization could provide a unique opportunity 
for identifying and engaging smokers, initiating 
cessation treatments, and facilitating appropriate 
follow-up and support procedures30.
A previous meta-analysis showed that smoking 
cessation programs were effective when they began 
during a hospital stay, regardless of the reason for 
admission, and when nicotine replacement therapy 
(NRT) was offered and a follow-up visit was 
provided at one month after discharge30. Therefore, 
health providers, should offer effective smoking 
cessation assistance to hospitalized smokers, 
regardless of the diagnosis or hospital unit, as 
shown in our study3. 
Internationally, several health organizations have 
adopted the 5As intervention model for smoking 
cessation proposed by evidence-based guidelines31. 
This model is based on five steps: 1) Ask patients 
about smoking at every visit; 2) Advise all tobacco 
users to quit; 3) Assess smoker’s willingness 
to try to quit; 4) Assist smoker’s efforts with 
treatment and referrals; and 5) Arrange follow-up 
contacts to support cessation efforts31. However, 
deficiencies persist in implementing smoking 
cessation interventions as part of routine practices 
in hospital settings32. One situation recognized to 
render smoking cessation interventions suboptimal 
is when the health professional is a smoker33,34. 
For instance, it was found that nurses that smoked 
were less likely to advise their patients to quit and 
less willing to arrange smoking cessation follow-up 
appointments34. In addition, a recent study conducted 
among health professionals in Catalonia showed that 
the clinical healthcare workers did not perform the 
5As completely35. The main barriers were: smoking 
cessation was considered not part of their job, lack of 
familiarity with practical guidelines, lack of previous 
positive experiences, and lack of organizational 
support35. 
To improve smoking cessation interventions, 
several hospitals have taken numerous actions, 
including providing training to health professionals 
and  reques t ing  compulsory  per formance 
indicators30,36,37.  Training has been strongly 
associated with higher levels of confidence, more 
frequent interventions, and fewer barriers to 
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providing cessation services38. 
In Catalonia, several actions have been undertaken 
to implement tobacco control interventions in 
hospitals, beyond the legislative framework39. In 
2000, the XCHsF promoted a ‘tobacco control 
hospital model’ that implemented organizational 
and cultural changes39. This model required the 
organization to make a commitment to adopting, 
integrally and progressively, a series of ten standards. 
This organizational change involved creating a policy 
working group that was integrated into the hospital 
management team and included key individuals in 
the institution (champions). This working group was 
responsible for designing the tobacco-control policy, 
scaling it down, and ensuring that it was properly 
communicated, monitored, and evaluated38. Thus, 
the working group must clearly communicate the 
policies to the other staff members, the patients, 
and the community. Currently, the tobacco control 
champions have shown extraordinary interest in 
the adoption, implementation, and evaluation of 
activities40,41. Because training is a key factor in the 
sustainability of these programs, the XCHsF has 
offered in-person and online training, which takes 
place every year and aims to reach a broad number 
of hospital workers42. 
The large prevalence of smokers with medium 
and high nicotine dependences (63.6% of smokers) 
has provided a strong rationale for offering drug 
treatment, such as nicotine replacement treatment 
(NRT). Currently, the majority of Catalan hospitals 
have implemented this therapeutic aid40. Clearly, the 
impact of these measures on increasing health care 
professionals’s interventions in providing tobacco 
cessation, patient smoking prevalence and cessation 
rates should be tested in future studies.
Limitations 
This study has several limitations. First, it is a cross-
sectional survey, and thus, our results cannot lead to 
any conclusions about direct causal effects; instead, 
our results only indicate associations. Second, this 
study relied on self-reported responses; however, 
tobacco consumption was verified with a CO-
oximeter. Third, we excluded patients admitted into 
emergency units and critical care units; thus, our 
sample might not be representative of all patients 
admitted into Catalan hospitals. In cases where 
admission to those units was related to smoking, 
omission of these data could lead to a bias in our 
results towards a lower prevalence of smoking. 
However, we implemented this exclusion criterion 
to assure the validity of our information, because 
all our patients were conscious in space and 
time. Fourth, due to our selection of hospitals by 
convenience, we could have introduced a selection 
bias, because it is possible that we chose only 
hospitals with the most interest in smoking cessation 
practices. However, that bias would have led to an 
underestimation of the current smoking problem 
in Catalan hospitals in this study. Nonetheless, this 
study was the first in Spain to explore smoking 
prevalence among hospitalized patients in multiple 
hospitals and units, with a large, representative 
sample size. 
CONCLUSIONS
Overall, 20.5% of hospitalized patients were current 
smokers, over 60% of smokers had medium or high 
nicotine dependences, and one-quarter smoked 
during hospitalization. Moreover, we found that 
about 75.7% of smokers expressed a wish to quit 
smoking, and half of them were ready or in a 
complentative stage to undertake an attempt. Our 
findings indicate that there is a need to initiate 
smoking cessation interventions among patients in 
all units and service areas during hospitalization. 
It is necessary to provide adequate therapeutic 
support and routine monitoring of patient 
cravings for cigarettes. The implementation of 
cessation interventions could avoid infringements 
of smoke-free policies and improve patient 
safety, hospital efficiency, and clinical outcomes. 
Future investigations should focus on testing the 
effectiveness of smoke-free policies combined 
with smoking cessation interventions initiated in 
hospitals. In addition, our findings indicate that 
these interventions should mainly focus on young 
patients that are not chronically ill. This study 
suggests that hospitalization represents a promising 
window for initiating smoking interventions 
addressed to all patients, particularly for patients 
who are men and without chronic diseases. Finally, 
health administrations, hospitals, and community 
services should work together to facilitate the 
initiation of smoking cessation treatments for 
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patients admitted to smoke-free hospitals, especially 
after applying smoke-free campus bans. 
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